2023 Dermatology Research to Ponder

To kick off the main program at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina, leaders in dermatology shared their review of dozens of pieces of literature worth pondering. Ted Rosen, MD; Matthew Zirwas, MD; and Sheila Fallon-Friedlander, MD, explained takeaways ranging from better ways to empathize with patients to treatment pearls.¹

References

1. Rosen T, Zirwas M, Fallon-Friedlander S. Dermatology literature in review 2023. Presented at Maui Derm NP+PA Fall 2023; September 27-30, 2023; Asheville, NC.

2. Barbieri JS, MacDonald K. Exploring discordance between patients and clinicians—understanding perceived disease severity. JAMA Dermatol. 2023;159(8):807–809. doi:10.1001/jamadermatol.2023.2007

3. EY Consumer Health Survey 2023. https://www.ey.com/en_us/health/ey-consumer-health-survey-2023. Published June 6, 2023. Accessed September 28, 2023.

4. Lergenmuller S, Rueegg CS, Perrier F, et al. Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women. JAMA Dermatol. 2022;158(12):1367-1377. doi:10.1001/jamadermatol.2022.4053

5. Khan AH, Gouia I, Kamat S, et al. Prevalence and severity distribution of type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis. Lung. 2023;201(1):57-63. doi:10.1007/s00408-023-00603-z

6. Kim JS, Lee IJ, Lee MG, et al. Periodontitis and risk of alopecia areata: A nationwide population-based cohort study in Korea. J Eur Acad Dermatol Venereol. 2023;37(3):e397-e399. doi:10.1111/jdv.18758

7. Mintoff D, Benhadou F, Pace NP, Frew JW. Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects. Int J Dermatol. 2022;61(10):1175-1186. doi:10.1111/ijd.15910